CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The T-OP project investigates how specific proteins, called cytokines, affect the effectiveness of adoptive T cell therapy for cancer treatment. By uniting experts in various fields, it aims to improve the production and clinical application of these therapies, enhancing their potential to combat tumors.
Over the last years, immunotherapy using a patients own immune system to fight tumours has emerged as an important complement to standard treatments.
The clinical implementation of immunotherapeutics has established T cells as efficient anti-cancer weapons if targeted by specific drugs.
Their therapeutic utilization has recently come to a breakthrough: adoptive T cell therapy (ACT), collecting and transforming the patients own T cells to treat cancer.
An estimated 753 different cell therapies…
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
TECHNICAL UNIVERSITY OF DENMARK DTU
Denmark, Kongens Lyngby
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Amsterdam
Type: Research institute
Activity type: Research Organisations
SME: No
Germany, Langen
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
